None of the COVID-19 vaccines approved for use in the U.S. have been approved for use in children under 16-years-old, but trials are underway to determine their safety and effectiveness in children.
Most recently, drug company Moderna has begun to test its COVID-19 vaccine to children under 12, including babies as young as six months.
Today on Wellness Wednesday on All Sides with Ann Fisher, we discuss how vaccine makers turn their attention to protecting kids from COVID-19.
Guests:
- John D. Corrigan, Ph.D., professor in the Department of Physical Medicine and Rehabilitation at Ohio State University and director of the Ohio Valley Center for Brain Injury Prevention and Rehabilitation
- Thomas Galligan, Ph.D., toxicologist on the Healthy Living Science team at Environmental Working Group
- Alexis Temkin, Ph.D., toxicologist with Environmental Working Group
- Dr. Octavio Ramilo, chief of Infectious Diseases at Nationwide Children’s Hospital
If you have a disability and experience difficulty accessing this content request an alternative format.
